Genus Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$12.7M |
| 2 |
Steel Dynamics
STLD
|
+$9.7M |
| 3 |
Cardinal Health
CAH
|
+$7.95M |
| 4 |
JB Hunt Transport Services
JBHT
|
+$7.64M |
| 5 |
Magna International
MGA
|
+$7.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$12.2M |
| 2 |
Corning
GLW
|
+$10.2M |
| 3 |
Merck
MRK
|
+$9.4M |
| 4 |
Gilead Sciences
GILD
|
+$9.38M |
| 5 |
Ulta Beauty
ULTA
|
+$8.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.42% |
| 2 | Financials | 18.38% |
| 3 | Consumer Discretionary | 8.22% |
| 4 | Healthcare | 7.77% |
| 5 | Industrials | 7.67% |
No holdings matched the selected filter criteria.
Similar funds
Genus Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Genus Capital Management held 229 positions worth $1.02B, up 16% from $873M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Genus Capital Management withdrew a net $32.8M in Q2 2026, closing 25 positions and reducing 84 holdings. Its most notable exit was Ciena, an estimated $5.44M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Genus Capital Management opened a new position in Cardinal Health worth $9.09M.
- Genus Capital Management's largest Q2 2026 buy was Cardinal Health: 38,270 shares worth $9.09M.
- Genus Capital Management added most to eBay in Q2 2026, an estimated $12.7M increase.
- Genus Capital Management's biggest Q2 2026 reduction was IBM, cutting an estimated $12.2M.
- Genus Capital Management fully exited Ciena in Q2 2026, selling an estimated $5.44M.
- Genus Capital Management's ten largest holdings make up 26% of its $1.02B portfolio in Q2 2026.
- Genus Capital Management opened 40 new positions and closed 25 in Q2 2026.
- Genus Capital Management's portfolio value rose 16% quarter-over-quarter to $1.02B.
Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.